Review of latent and lytic phase biomarkers in Kaposi's sarcoma

Author： Amin Milon   Pantanowitz Liron  

Publisher： Informa Healthcare

ISSN： 1753-0059

Source： Expert Opinion on Medical Diagnostics, Vol.7, Iss.6, 2013-11, pp. : 531-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Classic Kaposi's Sarcoma: A Review of 90 Cases

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 9, 1992-09 ,pp. : 548-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

Kaposi's Sarcoma

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 21, Iss. 10, 1973-10 ,pp. : 469-472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Killing of Kaposi's sarcoma‐associated herpesvirus‐infected fibroblasts during latent infection by activated natural killer cells

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1958-1968

John Wiley & Sons Inc

Access to resources Recommend Favorite

HIV-Associated Kaposi's Sarcoma

By  

Oncology Research and Treatment, Vol. 40, Iss. 3, 2017-02 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Alteration of Histone H3 Lysine 4 Trimethylation on Putative Lytic Gene Promoters by Human Set1 Complex during Reactivation of Kaposi’s Sarcoma-Associated Herpesvirus

By  

Intervirology, Vol. 56, Iss. 2, 2013-01 ,pp. : 91-103

Karger

Access to resources Recommend Favorite